Large study confirms locked-in syndrome as the predominant outcome of non-fatal pediatric drowning

It is a far cry from the traditionally thought-of “vegetative state” in which the mind is absent while the body lives on. Indeed, it is the opposite.

New biomarker could track progression of Alzheimer’s disease

Two pathologies drive the progression of Alzheimer’s disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles

July 14, 2023

NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu

NICE will reconsider Enhertu under its rapid review process, subject to the companies agreeing to lower the price. Credit: NICE. The UK National Institute for

July 30, 2024

EMA validates BMS’ Opdivo application for bladder cancer – Pharmaceutical Technology

The Phase III data was presented at the European Society for Medical Oncology (ESMO) Congress 2023. Credit: OGphoto via Getty Images. Bristol Myers Squibb’s (BMS)

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.